Market Overview:
The global antibody production market is expected to grow at a CAGR of 7.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for monoclonal antibodies and rising prevalence of chronic diseases. The polyclonal antibody segment is expected to dominate the market during the forecast period owing to its low cost and easy availability as compared to other types of antibodies. However, the monoclonal antibody segment is projected to grow at a higher CAGR during the forecast period, owing to its high specificity and affinity towards antigens. By application, pharmaceutical and biotechnology companies are expected account for majority of the market share duringthe forecast period followed by research laboratories.
Product Definition:
The production of antibodies, also called immunoglobulins, is the body's natural response to the presence of a foreign antigen. Antibodies are proteins that bind to and help destroy antigens. They are produced by plasma cells, which are white blood cells that originate in bone marrow.
Polyclonal antibody:
Polyclonal antibodies are made by B cells and are used in the detection of cancer or infections. They work by binding to antigens on the surface of bacteria, viruses, & other pathogens. The immune system is activated in response to these foreign substances resulting in an immune response.
The most common types of cancers that respond to polyclonal antibodies include skin melanomas and non-small cell lung carcinoma (NSCLC).
Monoclonal antibody:
Monoclonal antibody is a type of antibody, which is produced by the body's immune system to fight against bacteria, viruses or other harmful substances. The antibodies are attached with cell membranes and bring in actionable items for the pathogens. This process is called immunization and it works similarly to how vaccines work.
Application Insights:
Based on application, the global antibody production market is segmented into pharmaceutical and biotechnology companies, research laboratories and other institutions. The pharmaceutical segment dominated the overall market in terms of revenue in 2017. This was due to factors such as increasing prevalence of infectious diseases that require specific antibodies for treatment such as HIV/AIDS, hepatitis A & B viruses among others. Moreover, an increase in cancer cases has led to a rise in demand for monoclonal antibodies which are used for diagnosis and treatment purposes respectively.
The use of monoclonal antibodies has increased significantly across various industries such as food & beverage processing where they are used to detect counterfeit products or determine the quality of processed meat products among others applications that require high purity materials.
Regional Analysis:
Asia Pacific dominated the global market in 2017, with China and Japan contributing to a large extent. The presence of major pharmaceutical companies such as Novartis AG, Roche AG, Pfizer Inc., and others is expected to boost the production capacity for research purposes. In addition, increasing investments by biotechnology firms for drug discovery are anticipated to fuel growth over the forecast period.
The growing healthcare industry coupled with rising government spending on biotechnology R&D has resulted in high demand for antibodies globally. North America also accounted for a significant share owing to strong support from government agencies along with an increase in funding from private organizations such as Merck & Co., Inc.; FUJIFILM Diosynth Biotechnologies ULC; Thermo Fisher Scientific Inc.; among others (Table 1). Moreover, several key players have established manufacturing facilities within this region due to favorable regulations that enable easy access & export of goods across countries [1].
Growth Factors:
- Increasing demand for monoclonal antibodies for therapeutic and diagnostic applications
- Growing prevalence of cancer and other chronic diseases
- Rising investments in biotechnology and pharmaceutical industries
- Technological advancements in antibody production methods
- Growing awareness about the benefits of monoclonal antibodies
Scope Of The Report
Report Attributes
Report Details
Report Title
Antibody Production Market Research Report
By Type
Polyclonal antibody, Monoclonal antibody, Murine, Chimeric, Humanized
By Application
Pharmaceutical and biotechnology companies, Research laboratories, Others
By Companies
Thermo Fisher Scientific, Inc., GE Healthcare, Sartorius AG, Merck KGaA, Eppendorf AG, Cellab GmbH, Pall Corp., INTEGRA Biosciences AG, FiberCell Systems Inc., Thermo Fisher Scientific, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
212
Number of Tables & Figures
149
Customization Available
Yes, the report can be customized as per your need.
Global Antibody Production Market Report Segments:
The global Antibody Production market is segmented on the basis of:
Types
Polyclonal antibody, Monoclonal antibody, Murine, Chimeric, Humanized
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical and biotechnology companies, Research laboratories, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific, Inc.
- GE Healthcare
- Sartorius AG
- Merck KGaA
- Eppendorf AG
- Cellab GmbH
- Pall Corp.
- INTEGRA Biosciences AG
- FiberCell Systems Inc.
- Thermo Fisher Scientific, Inc.
Highlights of The Antibody Production Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Polyclonal antibody
- Monoclonal antibody
- Murine
- Chimeric
- Humanized
- By Application:
- Pharmaceutical and biotechnology companies
- Research laboratories
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antibody Production Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Antibody production is the process by which the body produces antibodies to fight against foreign invaders. Antibodies are proteins that help the body recognize and destroy harmful substances, such as bacteria or viruses.
Some of the major players in the antibody production market are Thermo Fisher Scientific, Inc., GE Healthcare, Sartorius AG, Merck KGaA, Eppendorf AG, Cellab GmbH, Pall Corp., INTEGRA Biosciences AG, FiberCell Systems Inc., Thermo Fisher Scientific, Inc..
The antibody production market is expected to grow at a compound annual growth rate of 7.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Antibody Production Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Antibody Production Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Antibody Production Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Antibody Production Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Antibody Production Market Size & Forecast, 2020-2028
4.5.1 Antibody Production Market Size and Y-o-Y Growth
4.5.2 Antibody Production Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Polyclonal antibody
5.2.2 Monoclonal antibody
5.2.3 Murine
5.2.4 Chimeric
5.2.5 Humanized
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pharmaceutical and biotechnology companies
6.2.2 Research laboratories
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Antibody Production Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Antibody Production Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Polyclonal antibody
9.6.2 Monoclonal antibody
9.6.3 Murine
9.6.4 Chimeric
9.6.5 Humanized
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pharmaceutical and biotechnology companies
9.10.2 Research laboratories
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Polyclonal antibody
10.6.2 Monoclonal antibody
10.6.3 Murine
10.6.4 Chimeric
10.6.5 Humanized
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pharmaceutical and biotechnology companies
10.10.2 Research laboratories
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Polyclonal antibody
11.6.2 Monoclonal antibody
11.6.3 Murine
11.6.4 Chimeric
11.6.5 Humanized
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pharmaceutical and biotechnology companies
11.10.2 Research laboratories
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Polyclonal antibody
12.6.2 Monoclonal antibody
12.6.3 Murine
12.6.4 Chimeric
12.6.5 Humanized
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pharmaceutical and biotechnology companies
12.10.2 Research laboratories
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Polyclonal antibody
13.6.2 Monoclonal antibody
13.6.3 Murine
13.6.4 Chimeric
13.6.5 Humanized
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pharmaceutical and biotechnology companies
13.10.2 Research laboratories
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Antibody Production Market: Competitive Dashboard
14.2 Global Antibody Production Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific, Inc.
14.3.2 GE Healthcare
14.3.3 Sartorius AG
14.3.4 Merck KGaA
14.3.5 Eppendorf AG
14.3.6 Cellab GmbH
14.3.7 Pall Corp.
14.3.8 INTEGRA Biosciences AG
14.3.9 FiberCell Systems Inc.
14.3.10 Thermo Fisher Scientific, Inc.
